Ammonia detoxification pathway enzymes (null)

Ammonia detoxification pathway enzymes Overview

Ammonia detoxification pathway enzymes comprise a group of enzymes essential for the conversion of toxic ammonia, produced primarily from amino acid breakdown, into excretable compounds such as urea and glutamine. The **urea cycle** is the principal route and takes place predominantly in the liver, utilizing enzymes such as carbamoyl phosphate synthetase I (CPS1), ornithine transcarbamylase, argininosuccinate synthetase, argininosuccinate lyase, and arginase[1][5][7]. **Glutamine synthetase** provides a parallel backup route by incorporating ammonia into glutamine, which is especially important in the brain, muscle, and perivenous hepatocytes[1][3][4]. Other supporting enzymes include glutamate dehydrogenase (in the glutamate dehydrogenase reaction), alanine aminotransferase, and enzymes of the purine nucleotide cycle[2]. Disruption in any of these enzymes may result in pathological ammonia accumulation, manifesting as metabolic disorders—including hepatic encephalopathy and inherited urea cycle disorders—with life-threatening neurological consequences. The pathway is a **therapeutic target in the context of hyperammonemia**, but as a term, "Ammonia detoxification pathway enzymes" lacks specificity, referring not to a single molecular entity but to a functional group of biochemically related enzymes[2][5][6]. This target name is too broad and refers to a group of enzymes and pathways rather than a single, specific molecular target. For structured data extraction or drug targeting, it is essential to specify individual enzymes, such as "Carbamoyl phosphate synthetase 1" or "Glutamine synthetase," rather than this pathway-level term.

Mechanism of Action

Activation of alternative ammonia elimination paths (e.g., conjugation with benzoate to form hippurate, with phenylacetate to form phenylacetylglutamine) - Enhancement or support of urea cycle function - Detoxification through increased excretion of alternative nitrogen carriers

Biological Functions

Safety Considerations

Interacting Drugs

Associated Biomarkers